HOTH
Income statement / Annual
Last year (2023), Hoth Therapeutics, Inc.'s total revenue was $0.00,
and the percentage change from the previous year is not available.
In 2023, Hoth Therapeutics, Inc.'s net income was -$7.85 M.
See Hoth Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
| Operating Revenue |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
| Cost of Revenue |
$0.00 |
$66,834.00 |
$46.87 M |
$25,871.00 |
$31,622.00 |
$28,252.00 |
$188.00 |
| Gross Profit |
$0.00 |
-$66,834.00 |
-$46.87 M |
-$25,871.00 |
-$31,622.00 |
-$28,252.00 |
-$188.00 |
| Gross Profit Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Research and Development
Expenses |
$3.48 M
|
$4.93 M
|
$7.53 M
|
$2.89 M
|
$2.12 M
|
$1.02 M
|
$586,843.00
|
| General & Administrative
Expenses |
$4.21 M
|
$6.13 M
|
$6.57 M
|
$3.96 M
|
$5.06 M
|
$1.22 M
|
$320,123.00
|
| Selling & Marketing
Expenses |
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$0.00
|
$964,327.00
|
| Selling, General &
Administrative Expenses |
$4.21 M
|
$6.13 M
|
$6.57 M
|
$3.96 M
|
$5.06 M
|
$1.22 M
|
$1.28 M
|
| Other Expenses |
$0.00 |
$451,140.00 |
-$212,265.00 |
$454,207.00 |
$538,577.00 |
$258,710.00 |
$0.00 |
| Operating Expenses |
$7.69 M |
$11.07 M |
$14.10 M |
$7.30 M |
$7.71 M |
$2.50 M |
$1.87 M |
| Cost And Expenses |
$7.69 M |
$11.07 M |
$14.10 M |
$7.30 M |
$7.71 M |
$2.50 M |
$1.87 M |
| Interest Income |
$781.00 |
$6,370.00 |
$0.00 |
$8.00 |
$25.00 |
$0.00 |
$216,000.00 |
| Interest Expense |
$0.00 |
$305,409.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
$0.00 |
| Depreciation &
Amortization |
$7.69 M
|
$11.07 M
|
$1,043.00
|
$1,043.00
|
$1,225.00
|
$1,224.00
|
$188.00
|
| EBITDA |
-$153,149.00
|
$0.00
|
-$14.10 M
|
-$7.30 M
|
-$7.71 M
|
-$2.49 M
|
-$2.02 M
|
| EBITDA Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| Operating Income Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Total Other
Income/Expenses Net |
-$153,148.00
|
-$306,399.00
|
-$212,265.00
|
$104,158.00
|
$10,361.00
|
$0.00
|
-$143,999.00
|
| Income Before Tax |
-$7.85 M |
-$11.37 M |
-$14.31 M |
-$7.20 M |
-$7.70 M |
-$2.50 M |
-$2.02 M |
| Income Before Tax Ratio
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
| Income Tax Expense |
$0.00 |
$305,409.00 |
-$1.04 |
-$205,254.00 |
-$10,361.00 |
-$159,917.00 |
$2.00 |
| Net Income |
-$7.85 M |
-$11.68 M |
-$14.31 M |
-$7.20 M |
-$7.69 M |
-$2.50 M |
-$2.02 M |
| Net Income Ratio |
0 |
0 |
0 |
0 |
0 |
0 |
0 |
| EPS |
-2.3 |
-9.75 |
-16.03 |
-14.56 |
-20.99 |
-6.62 |
-5.24 |
| EPS Diluted |
-2.3 |
-9.75 |
-16.03 |
-14.56 |
-20.99 |
-6.62 |
-5.24 |
| Weighted Average Shares
Out |
$3.41 M
|
$1.20 M
|
$893,203.00
|
$494,513.00
|
$366,583.00
|
$376,982.00
|
$384,482.00
|
| Weighted Average Shares
Out Diluted |
$3.41 M
|
$1.20 M
|
$893,203.00
|
$494,513.00
|
$366,583.00
|
$376,982.00
|
$384,482.00
|
| Link |
|
|
|
|
|
|
|
